Page last updated: 2024-08-25

efaroxan and atipamezole

efaroxan has been researched along with atipamezole in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agbaba, D; Azzali, E; Costantino, G; Glisic, S; Laurila, JM; Nikolic, K; Perovic, V; Pieroni, M; Radi, M; Scheinin, M; Srdic-Rajic, T; Tassini, S; Veljkovic, N; Vucicevic, J	1
Cahill, CM; Grenier, P; Olmstead, MC; Wiercigroch, D	1

Other Studies

2 other study(ies) available for efaroxan and atipamezole

Article	Year
A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin. Bioorganic & medicinal chemistry, 2016, 07-15, Volume: 24, Issue:14 Topics: Adrenergic alpha-Agonists; Antibiotics, Antineoplastic; Apoptosis; Doxorubicin; Drug Synergism; Humans; K562 Cells; Ligands; Molecular Structure; Oxazoles; Receptors, Adrenergic, alpha-2; Rilmenidine	2016
Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists. Behavioural pharmacology, 2018, Volume: 29, Issue:2 and 3-Sp Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Drug Tolerance; Gliosis; Imidazoles; Injections, Spinal; Male; Morphine; Neuroglia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Spine	2018

Article

Year

A combined ligand- and structure-based approach for the identification of rilmenidine-derived compounds which synergize the antitumor effects of doxorubicin.

Bioorganic & medicinal chemistry, 2016, 07-15, Volume: 24, Issue:14

Topics: Adrenergic alpha-Agonists; Antibiotics, Antineoplastic; Apoptosis; Doxorubicin; Drug Synergism; Humans; K562 Cells; Ligands; Molecular Structure; Oxazoles; Receptors, Adrenergic, alpha-2; Rilmenidine

2016

Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists.

Behavioural pharmacology, 2018, Volume: 29, Issue:2 and 3-Sp

Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Cannabinoid Receptor Antagonists; Cannabinoids; Dose-Response Relationship, Drug; Drug Tolerance; Gliosis; Imidazoles; Injections, Spinal; Male; Morphine; Neuroglia; Norepinephrine; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Spine

2018